Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Cognite

- PMLiVE

Connecting through the chaos – why medical affairs needs creative problem-solving

By Ali Walsh

- PMLiVE

Sanofi and Regeneron’s Dupixent receives positive NICE final draft guidance for COPD

Around 1.4 million people in the UK are diagnosed with COPD, with two million thought to be undiagnosed

- PMLiVE

Regeneron’s Libtayo receives EC approval for skin cancer

Phase 3 trial results showed the drug significantly improved disease-free survival

- PMLiVE

Reimagining pharma CX: three game-changing products driving human-centric innovation

By Rachael McLoughlin

- PMLiVE

Doctored Truths urges pharma to lead the fight against health misinformation

“Doctored Truths” exposes the escalating crisis of health misinformation and disinformation, which has been ranked the world’s top short-term risk to the world, for the second year in a row....

Havas Lynx

- PMLiVE

Havas Lynx appoints Talin Apkarian as Havas Lynx Hudson managing director

Apkarian most recently served as executive vice president, group management director at Humancare

- PMLiVE

Havas Lynx appoints Ayesha Walawalkar as chief strategy officer

Walawalkar most recently served as chief strategy officer, international brands at MullenLowe Global, part of IPG

- PMLiVE

Havas Lynx Welcomes New Leadership Hires

Havas Lynx announces the appointment of Ayesha Walawalkar as Chief Strategy Officer, and Talin Apkarian as Havas Lynx Hudson Managing Director.

Havas Lynx

Genetic Digital has been shortlisted for a PM Society Digital Award for Epilepsy Meds.

Genetic Digital Shortlisted for PM Society Digital Award for Epilepsy Meds App

Genetic Digital has been shortlisted for a PM Society Digital Award for Epilepsy Meds, a mobile-first app that helps healthcare professionals make safer, patient-specific prescribing decisions in epilepsy care. The...

Genetic Digital

- PMLiVE

Havas to Open New Manchester Village at Circle Square

The global communications group will unite six agencies under one roof in a purpose-built, hybrid workspace at the heart of Manchester’s innovation district

Havas Lynx

- PMLiVE

Sanofi/Regeneron’s Dupixent granted FDA approval for bullous pemphigoid

Around 27,000 adults in the US are living with uncontrolled cases of the chronic skin disease

- PMLiVE

Sanofi/Regeneron share results for Dupixent in atopic dermatitis patients with darker skin tones

These are the first clinical study results for the drug in a large population of patients with darker skin tones

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links